In this article
Key takeaways
- Many people develop opioid, benzodiazepine, or alcohol dependence through legitimate attempts to manage chronic pain that conventional medicine failed to adequately address.
- Chronic pain and addiction share dysregulated neurological pathways, particularly in dopamine reward and opioid systems, creating bidirectional vulnerability between the two conditions.
- Opioid-induced hyperalgesia paradoxically increases pain sensitivity over time, requiring higher doses while simultaneously making the underlying pain worse.
- Effective treatment requires multimodal pain rehabilitation combined with addiction therapy delivered in parallel, not sequentially, by interdisciplinary teams with dual competency.
- Medically supervised opioid tapering over weeks or months is significantly more likely to succeed than rapid detoxification in people with coexisting chronic pain and addiction.
How pain and addiction become entangled
The relationship between chronic pain and addiction is bidirectional and complex. For a significant proportion of people in treatment for substance use disorders, the original use of the substance was not recreational. It was therapeutic - an attempt to manage pain that conventional medicine had failed to adequately address, or pain for which opioids had been legitimately prescribed.
In the United States, the opioid epidemic is largely a story of prescribed pain management that became dependency. In Australia, the UK, and elsewhere, similar patterns emerge at smaller scale. But opioids are not the only substance implicated. Benzodiazepines, prescribed for the anxiety and sleep disruption that frequently accompany chronic pain, create their own dependence. Alcohol - available without prescription, immediately effective at numbing both physical and psychological pain - is perhaps the most common self-medication for chronic pain globally.
Understanding this pathway matters for treatment, because addressing addiction without addressing the underlying pain is likely to fail, just as addressing pain with the same substances that created the dependence in the first place perpetuates the cycle.
The neurological overlap between pain and addiction
Chronic pain and addiction share neurological substrate in ways that are not coincidental. Both conditions involve dysregulation of the same neurological systems - particularly the dopamine reward pathway and the opioid system. Chronic pain alters brain structure and function in ways that increase vulnerability to addiction. And addiction, in turn, alters pain perception - typically increasing sensitivity to pain (a phenomenon called hyperalgesia) in ways that make the underlying pain worse.
Is this something you're dealing with?
Free confidential advice - no pressure, no obligation.
Opioid-induced hyperalgesia is particularly important to understand. Long-term opioid use paradoxically increases pain sensitivity, so that over time the person requires increasing doses to achieve the same pain control, while simultaneously experiencing more pain from the drug-induced sensitisation. This is one reason why chronic high-dose opioid treatment for non-cancer pain frequently fails - not because the person is not in genuine pain, but because the opioids themselves are making the pain worse.
The emotional dimensions of pain - how pain is experienced, how threatening it feels, how much it dominates attention - are mediated by the same circuits that process stress, fear, and emotional salience. Both chronic pain and addiction can create what neurologists describe as a threat hypervigilance state, in which the nervous system is chronically primed for threat in ways that amplify suffering and narrow behavioural options.
What effective treatment looks like for co-occurring pain and addiction
The clinical consensus has shifted substantially over the past twenty years away from opioid-centred pain management and toward multimodal approaches that address the neurological, psychological, and physical dimensions of chronic pain without relying on substances that create dependency. This is sometimes called the biopsychosocial model of pain management, and its evidence base is substantially stronger than continued opioid prescribing for most forms of chronic non-cancer pain.
Pain rehabilitation rather than pain management
Traditional pain management focuses on reducing the pain signal - typically through medication, injection, or surgery. Pain rehabilitation takes a different approach: it focuses on improving function and quality of life despite the presence of pain, rather than eliminating pain as a precondition for living. This distinction is not semantic. Many people with chronic pain will not achieve complete pain relief through any means. The goal becomes living well with manageable, if not absent, pain.
Pain rehabilitation programmes use a combination of graded physical exercise (which has direct analgesic effects through endogenous opioid release and central sensitisation reversal), psychological therapies including CBT and Acceptance and Commitment Therapy (ACT), physiotherapy, and sometimes occupational therapy. They are typically delivered in multidisciplinary settings.
Addressing the addiction component
For people who have developed dependence on opioids, benzo or alcohol in the context of chronic pain, addiction treatment must proceed in parallel with pain rehabilitation rather than sequentially. Expecting someone to address addiction first and then their pain, or vice versa, is clinically unrealistic. The two conditions reinforce each other and must be treated together as dual diagnosis.
This means that residential programmes treating this population need both clinical competency in addiction and genuine capability in chronic pain management - including pain psychology, physical rehabilitation, and informed prescribing that can safely manage withdrawal from pain medications while supporting pain relief through non-addictive means.
The role of non-opioid pain treatments
Several medication classes are effective for chronic pain without the addiction liability of opioids: anticonvulsants such as gabapentin (though this class has its own dependence risks at high doses), tricyclic antidepressants, SNRIs, and topical agents. Interventional procedures - nerve blocks, spinal cord stimulation - may be appropriate for specific pain conditions. Mindfulness-based stress reduction (MBSR) has a substantial evidence base for chronic pain and operates through neurological mechanisms quite distinct from medication.
Gabapentinoids and dependency: Gabapentin and pregabalin (Lyrica) - widely prescribed for neuropathic pain - carry their own dependency and misuse risk that is significantly underappreciated. They potentiate the effects of opioids and alcohol, making them particularly dangerous in this population. Anyone taking these medications as part of pain management should ensure that their prescriber is aware of any addiction history.
Withdrawal from long-term opioids in people with chronic pain
Opioid withdrawal is profoundly unpleasant even in people who do not have chronic pain. In people whose baseline is already characterised by significant physical pain, opioid withdrawal can be experienced as unbearable - not only because of the withdrawal syndrome itself but because the withdrawal period unmasks the underlying pain in its full intensity, often amplified by opioid-induced hyperalgesia. This is one of the primary reasons people with chronic pain and opioid dependence relapse rapidly after stopping without structured support.
Medically supervised opioid tapering - reducing the dose slowly over a period of weeks to months, rather than stopping abruptly - is significantly more tolerable and more likely to succeed than rapid detoxification. The taper rate should be individualised based on the duration of opioid use, the dose, and the person's clinical state. Adjunctive medications can manage some of the withdrawal symptoms. Pain management strategies should be optimised as the opioid dose reduces.
The psychological dimension of pain and addiction
For many people with chronic pain and addiction, the substance use serves a psychological function that extends beyond pain relief: it manages the despair, isolation, and loss of identity that chronic pain creates. Living with unremitting pain is profoundly demoralising. It disrupts work, relationships, physical capacity, and self-concept. Substances - at least initially - restore some of what pain has taken away.
Therapy that addresses only the addiction without attending to the psychological impact of chronic pain is unlikely to succeed. Approaches like Acceptance and Commitment Therapy (ACT), which works directly on the relationship between pain, suffering, avoidance, and values-based action, are particularly well-suited to this population. The goal is not to convince the person that their pain is not real or not severe. It is to help them build a life that is workable despite the pain - which requires accepting its presence rather than organising life around its elimination. Integrating trauma-informed approaches is also valuable, as many people with chronic pain have experienced medical trauma or adverse events that compound the psychological burden.
Looking for specialist support?
Our team can help you find the right programme for complex presentations involving pain and addiction. No obligation, strictly confidential.
Sources
- National Institute on Drug Abuse. Addiction Science. NIDA.
- SAMHSA National Helpline. Find Help - National Helpline. Substance Abuse and Mental Health Services Administration.
- Volkow, N.D., & McLellan, A.T. 2016. Opioid Abuse in Chronic Pain - Misconceptions and Mitigation Strategies. New England Journal of Medicine, 374(13), 1253-1263.